WDR5 has been found to be overexpressed in various cancers, including leukemia [4], breast cancer [5], lung cancer [6], and bladder cancer [7], suggesting its potential as a therapeutic target for cancer treatment [8]. This evidence concerns the gene WDR5 and leukemia.